Navigation Links
What is the suppressing effect of the PPAR-gamma ligands on stomach cancer cells?
Date:2/17/2009

PPAR- gamma is manifested in a variety of tissues and cancer cells and the ligands that activate PPAR- PPAR- are currently being studied as a novel treatment. The PPAR-gamma ligand generally decreases the survival rate of cancer cells via differentiation, apoptotic induction, and changes in genes or proteins associated with entrance into the G1/S phase. There have been some reports suggesting that stomach cancer cells manifest PPAR- gamma and are suppressed by the PPAR- gamma ligand. Recently, another report has shown that troglitazone, the ligand of PPAR- gamma , may prove useful in preventive medicine, and this effect is dependent on PPAR- gamma .

A research article to be published in volume 15 on January 21, 2009 in the World Journal of Gastroenterology addresses this point. A research team led by Professor DH Kim from the Medical Research Institute, Pusan National University Hospital, Korea found that the reaction of the PPAR- gamma agonist pathway on PPAR- gamma , troglitazone, suppresses the proliferation of colon cancer cells, and induces apoptosis, and expression of the growth response-1 gene in early phase. These processes are activated downstream of the suppression one by one via a PPAR- gamma -independent pathway. Moreover, an inductive chemical compound associated with CDDO causes PPAR- gamma -dependent caveolin expression and a PPAR- gamma -independent induction of the apoptosis reaction.

This report shows that ciglitazone and troglitazone suppress the proliferation of stomach cancer cells via the arrest of G1 phase. The arrest of G1 phase was reported in colon cancer cells via activation of PPAR- gamma. Also, each of the stomach cancer cell types which demonstrated p53 mutations were suppressed more strongly by troglitazone than by ciglitazone, and this effect was more evident in the SNU-668 than in the SNU-216 cells. SNU-668 cells demonstrated p53 and ras mutations, and it will be necessary in future studies to clari
'/>"/>

Contact: Lin Tian
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Escape cancer, but age sooner? The dark side of the tumor suppressing process
2. USC researchers identify novel approach for suppressing prostate cancer development
3. Cancer-Suppressing Gene Tied to Female Fertility
4. Study shows suppressing herpes virus may reduce infectiousness of HIV
5. MU researcher demonstrates non-traditional therapy is effective as pain management
6. Absolutely PR's Maggie Holben Participates In CBSA BioBreakfast Expert Panel "How to Garner Media Attention & Effectively Use Public Relations Tactics"
7. Newly Published Menopause Study: Bioidentical and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
8. Drug Rehab Mountainside Treatment Center is an Effective and Quality Option for Those Seeking Drug Treatment - Located Close to NY MA
9. The Effects of Probiotics on the Aging Digestive Tract to be Presented at Nutracon 2009
10. Potential atherosclerosis drug exhibits no harmful side-effects in liver
11. Union Springs Pharmaceuticals Introduces New, More Effective Respirator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... with its top dressmaking technologies, has been a leading dress ... its latest designs of wedding dresses and launching a site-wide ... all the fresh new products are designed for 2015, and ... off. All the clothes from LunaDress follow up with the ...
(Date:1/22/2015)... 22, 2015 Padre Murphy's and Owner Tom ... Pro Player Health Alliance (PPHA). The PPHA's passion ... getting everyone, including NFL greats, treated for obstructive sleep apnea ... groups supporting the cause in the valley. The most recent ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
(Date:1/22/2015)... A new white paper by The Beryl Institute ... long-term care environment as well as provides recommendations for ... “The Power of Person-Centeredness in Long-Term Care: A View ... patient, resident and family experience in long-term care and ...
(Date:1/22/2015)... released a new blog post presenting the basic features of ... an accidental death and dismemberment rider for a car insurance ... benefits if the insured dies in an accident. Accidental death ... insurance. , AD&D is not expensive and can be ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2
... to revolutionize senior home care industry!PALO ALTO, Calif., ... Alto, California released its new caregiver training program ... exclusive to Home Care Assistance 1-866-4-LiveIn(TM), promotes longevity ... an emphasis on lifestyle, healthy diet, physical activity, ...
... Kidz-Med ThermofocusWESTON, Fla., May 22 Kidz-Med, Inc., a ... is excited to see that awareness for a new ... taking a child,s temperature with the Kidz-Med Thermofocus 5-in-1 ... The Doctors , renowned pediatrician Dr. Jim Sears, ...
... 22 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. ("Bioniche"; ... today provided an update on its Phase III ... bladder cancer. On March 31st, the Company announced ... Phase III registration trial evaluating Urocidin in the ...
... protein linked to tumor growth for clues to better treatments ... have found that levels of the protein caveolin-1 found in ... predict a patient,s prognosis and may provide a pathway to ... a role in how cells absorb things, in the stromal ...
... is what leads to well-being , , FRIDAY, May 22 (HealthDay ... may sound like a sure ticket to happiness, but a ... Rochester in New York tracked 147 college graduates, evaluating their ... one year after graduation, and then 12 months later. , ...
... to manufacturers by month,s end , , FRIDAY, May 22 (HealthDay ... a bit nearer Friday, with government health officials saying they ... shot. , "Today CDC received, from one institution, a candidate ... Science and Public Health Program said during a Friday news ...
Cached Medicine News:Health News:Home Care Assistance's Exclusive Balanced Care Method(TM) Designed to Promote Longer, Healthier Lives 2Health News:Home Care Assistance's Exclusive Balanced Care Method(TM) Designed to Promote Longer, Healthier Lives 3Health News:Awareness Increases on New Health and Safety Technology for Kids 2Health News:Awareness Increases on New Health and Safety Technology for Kids 3Health News:Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well 2Health News:Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well 3Health News:Looks, Money, Fame Don't Bring Happiness 2Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 2Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 3Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 4Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 5Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 6Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 7Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 8Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 9Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 10Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 11Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 12Health News:CDC Has Candidate Viruses for Swine Flu Vaccine 13
(Date:1/23/2015)... , Jan. 23, 2015 Cord Blood America, Inc. ( ... or the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, ... today, and provides an update for shareholders detailing why a ... requested. Dear Shareholders, As we reflect ...
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
(Date:1/23/2015)... Ala. , Jan. 23, 2015 Gem Pharmaceuticals ... patients have been enrolled into the Company,s Phase 2 ... and safety of Gem,s lead compound, GPX-150 (an investigational ... advanced or metastatic disease. Logo - ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... , , ... 2009 Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced ... trial in patients chronically infected with the hepatitis C virus (HCV). The ... antiviral effect of clemizole monotherapy in the absence of interferon. ...
... , , LYON, France ... the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and ... submitted to the U.S. Food and Drug Administration (FDA) a ... vaccine. Responding to recent recommendations by the FDA, the company,s ...
Cached Medicine Technology:Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 2Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 3Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA 2Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA 3
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique. Round knurled handle. Manufactured in titanium....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
7 mm flattened hook. Flat serrated handle with polished finish. Overall length: 4.9 inches....
Left angled 5 mm blunt hook. Overall length: 9.9 inches....
Medicine Products: